ACCESS TO TREATMENT FOR NEGLECTED DISEASES – Experiences In Marsabit County Presented by: Abduba Liban CDSC, Marsabit County 0n 9 th February 2016 at the.

Slides:



Advertisements
Similar presentations
Follow-up after training and supportive supervision The IMAI District Coordinator Course.
Advertisements

Mongolia Sub-national situation of patient safety D. Doljin, Director, Regional Diagnostic and Treatment Center for Eastern provinces (Dornod, Sukhbaatar.
Haemoflagellates Leishmaniasis & Trypanosomiasis
Leishmaniasis LTC Glenn Wortmann, MD Associate Program Director, ID Fellowship Infectious Diseases Service Walter Reed Army Medical Center.
Rakai Health Sciences Program (RHSP) Uganda Population-based Research on HIV, other Infectious Diseases, Reproductive Health and Service delivery.
Reason for Blood Donor Deferral for Exposure to Leishmaniasis Presented by deployment illness advocate Venus-Val Hammack 12/11/03 HQ: Mass State House,
CHINESE CENTER FOR DISEASE CONTROL AND PREVENTION Epidemiology Investigation for Ebola Virus Disease Lei Zhou, MD, Epidemiologist Public Health Emergency.
Overview of Progress in Malaria Control in Kenya
Edo Agustian Indonesian Drug Users Network Experiencing HCV Infection – the treatment, the reality and the possibilities for Cure.
How to IMPLEMENT responses. Who and when ? IMMEDIATEPERIODICLONG TERM Region National Woreda Facility Comm’ty Level and timing of action.
Accelerating TB/HIV activities in Zambia Alwyn Mwinga 2007 HIV Implementers Meeting 20 June 2007.
OnSite Leishmania Ab Rapid Test (Strip) Leishmania IgG / IgM Rapid Test A Leading Product On Market by Using CTK Licensed Patented Antigen.
Efficacy and Safety outcomes: Liposomal Amphotericin B (Ambisome) treatment for Visceral Leishmaniasis (VL) under routine programme conditions in Bihar,
1 AIDS 2010 Vienna, July 2010 HIV/AIDS and People from Countries where HIV is endemic – Black people of African and Caribbean descent living in Canada.
SISTERS SUPPORT NETWORK (SSN) WORKS AND ACTIVITES By Mary Agyapong (Co-Founder and Executive Secretary)
Community Feedback and Involvement in [Health Department’s] Proposed Data to Care Program [Name of Provider Session Date of Provider Session]
Cross Border Animal Health Plan of Action – Kenya and Uganda Four Strategic areas 1. To improve prevention, management and control of cross border animal.
HOME AND AMBULATORY BLOOD PRESSURE MONITORING
Leishmaniasis (Leishmania). caused by intracellular protozoan parasites of the genus Leishmania transmitted by phlebotomine sandflies disease involving.
Sand Fly Surveillance in Kenya: the Need to Update Vector and Pathogen Distributions CPT Jeffrey Clark Elizabeth Kioko Unclassified.
Visceral Leishmaniasis {(Kala-azar) (Dum-Dum fever, Black fever)}
Leishmaniasis.
HEALH CARE DELIVERY SYSTEM General Hospital l Facility where patients are hospitalized a short time (few days to a few weeks) l Provide a wide range.
RVF outbreak in SA, Feb - May 2010 JOINT BRIEFING BY: DEPARTMENT OF AGRICULTURE, FORESTRY AND FISHERIES (DAFF) AND DEPARTMENT OF HEALTH.
Are patients with chronic diseases a new challenge to general practice? Organizing preventive health services to patient with chronic diseases Why do clinics.
Malaria Case management KPA conference. Presentation outline  Introduction  National malaria strategy  Case management targets  AMFm subsidy  The.
ALZAIEM ALAZHARI UNIVERSITY Faculty of public & Environmental health Seminar on BY: ZAKIA ELGALI MAY 2005.
Omondi Robert Sadia University of Nairobi
MSF Experience: Leishmaniasis control in Fulbaria Upazilla of Mymensing district Date: 1 st September, 2012.
Beyond Sputum Cups and Four Drugs The Responsibility of the Practicing Clinician in the Community Control of Tuberculosis V. R. Koppaka, MD, PhD Division.
Ministry of Health Kenya Guinea Worm Eradication Programme Laico Regency Hotel - 26 th August 2015 Guinea worm disease1.
Methodological challenges for AMR surveillance programmes Gous AGS, Pochee E School of Pharmacy Medical University of Southern Africa.
Livesy Abokyi Kintampo Health Research Centre 9 th INDEPTH AGM th October,2009 Pune, INDIA.
The blood tissue flagellates Leishmania and Trypanosoma.
Strengthening SME system for national programmes moving from transmission reduction to elimination phase Cambodia.
Haemoflagellates Leishmaniasis & Trypanosomiasis.
MT. MALARAYAT GOLF & COUNTRY CLUB LIPA CITY, BATANGAS, PHILIPPINES 10 TH TO 18 TH FEBRUARY 2014 MALARIA ELIMINATION SURVEILLANCE SYSTEM REVIEW.
INDIAN RAILWAY MEDICAL SERVICE
MSF TB Program for Migrants in Tak. Beginnings: MSF TB Programs in Thailand First MSF TB Program in Thailand started in 1985 in Karen camps (Shoklo,
KALA AZAR Leishmaniasis is a disease caused by protozoan parasites of to the genus Leishmania and is transmitted by the bite of sand fly. This disease.
Malaria pan-R Malaria cassette. Agenda Disease overview Infectious agents Diagnosis pan-R Malaria cassette: specifications Conclusion.
Public health impacts of donor screening for T. cruzi infection Susan P. Montgomery, DVM MPH Division of Parasitic Diseases Centers for Disease Control.
Ebola preparedness and Response in Lao PDR. Outline Objective The preparedness contingency plan Phase 1: Preparedness Phase 2: Contingency for response.
Rapid decentralised scale-up of HIV care and treatment in Suba District MOH health facilities.
Turkmenistan case study Outbreak Identification of actions to strenghten the health system.
SSG & PM: Issues of Access to VL treatments
Visceral Leishmaniasis treatment access: The reality on the ground Margriet den Boer KalaCORE Regional Coordinator , East Africa Symposium Innovation.
Tissue flagellates Mrs. Dalia Kamal Eldien MSC in microbiology Lecture NO 8.
TB in Yorkshire and the Humber Dr Simon Padfield 14 th Sept 2007.
Definition of indicators Facilitators’ Workshop on District Health Performance Improvement Lilongwe, 25 th – 27 th March 2015.
2014 Kenya Demographic and Health Survey (KDHS) Fertility Follow along on
Provider Initiated HIV Counseling and Testing Unit 2: Introduction and Rational for PIHCT.
5 TH NATIONAL QUALITY IMPROVEMENT FORUM: KILIMANJARO HOTEL 2015: Theme: Contribution of quality improvement in attainment of health and social welfare.
EBOLA OUTBREAK – LIBERIA, Current Status Scale and evolution of outbreak outpacing strategy and plans – 14 of 15 counties now affected – Major urban.
Hand foot mouth disease. It is a frequent viral infection in children below 5 years due to infection by enterovirus mostly coxackie A16. It is highly.
Kala-azar Situation in Bangladesh
LEAP: Contributing to Strengthening Clinical Trial Capacity, Treatment and Control of VL in Eastern Africa Asrat Hailu, LEAP Chair, Addis Ababa University.
Umm Al-Qura University
Species name Disease: common name(?) Number of cases worldwide:
Leishmaniasis.
Active and passive case detection strategies for the control of VISCERAL leishmaniasis (KALA AZAR) in Bangladesh Prepared by: Manimoy Chakma MSF-OCA, Bangladesh.
TB- HIV Collaborative activities in Romania- may 2006 status
ABSTRACT THE IMPACT OF CONTINUOUS MEDICAL EDUCATION ON PRESCRIBING
EmONC Scale-up In Kenya Results of Health Facility Assessments
This is an archived document.
Leishmaniasis.
Content Public Health Emergencies Ebola Virus Disease: DRC
Dr Paul T Francis, MD Community Medicine College of Medicine, Zawia
لیشمانیازیس این بیماری یک بیماری مشترک بین انسان و حیوان می باشد.
Leishmania donovani By: Kamran Ahmed.
Presentation transcript:

ACCESS TO TREATMENT FOR NEGLECTED DISEASES – Experiences In Marsabit County Presented by: Abduba Liban CDSC, Marsabit County 0n 9 th February 2016 at the ASTMH Conference

OUTLINE 1. Brief county profile 2. Status of kala-azar marsabit county 3. Diagnosis and Treatment of Kala azar in Marsabit 4. Challenges of Accessing Treatment 5. Addressing the challenges at County Level 6. Way forward

Marsabit County

County Profile

County Population

Visceral leishmaniasis VL (Kala azar)  Kala azar a systemic parasitic disease  It is transmitted through infected female sand fly.  There are three forms of leishmaniasis; Visceral leishmanaisis (VL), Cutaneous, Muco-cutaneous  There are three endemic foci in kenya o Northwest Kenya - West Pokot, Baringo and Turkana o Eastern Province - Machakos, Kitui, Mwingi and kyuso o North-eastern Province - along the Somali border

Visceral Leishmaniasis in Marsabit  VL is the common form leishmania in Marsabit  VL is a new problem in Marsabit county  There is only one treatment centre for kala azar in Marsabit – Marsabit Hospital  Distance from the furthest endemic region to the centre is 500km

Kala-azar Cases by Months

Kala-azar Cases by Locations

Diagnosis & Treatment of Kala-azar in Marsabit Diagnosis and treatment is based on the Kenyan VL guidelines Diagnosis  A patient should be suspected in a patient from, or visiting, an endemic area who presents with: o Fever > 2 weeks o Splenomegaly o Weight loss o Diagnosis through rapid test kits – rK39

Diagnosis & Treatment of Kala-azar in Marsabit Diagnosis and treatment is based on the Kenyan VL guidelines Treatment If patient is found positive after all differentials are ruled out, they are:  Admitted in the hospital  Placed on 17 day treatment with SSG & PM (first line treatment)  Second line treatment - Ambisome

Challenges of Accessing Treatment Community Level Challenges  Distance to the treatment centre  Lack of awareness of the disease  Cultural practices (seeking traditional treatments for disease) Supply and Purchase Challenges  Treatments are available mainly through donations from partners  Treatments are usually very expensive  Treatments not usually available in KEMSA or MEDs

Challenges of Accessing Treatment Health - Worker Level Challenges  Lack of training of healthworkers: o Doctors administer SSG alone and do not adhere to SSG&PM o Leading to misdiagnosis o Very few health-workers are trained in specialized procedures such as bone marrow and splenic aspirates

Addressing the challenges at County Level  Improved Surveillance and Reporting: o Reported the increase to next level of health system o Reinforced the surveillance system o Made weekly data reporting mandatory  Treated all confirmed cases using appropriate drugs therapy  Training of hospital and health centre staff in diagnosis and treatment protocols

 Advocacy Communication and Social Mobilization: o Health education to the communities. o Created awareness on leishmaniasis prevention and control measures o Development and distribution of brochures and banners o Talk shows in local radio stations  Undertaken vector surveillance and control measures Addressing the challenges at County Level

Conclusions and Way forward  There is need to prioritize VL and purchase of treatments and diagnostics  Improved awareness creation, advocacy and communication  Consistency in supplies  Training of health workers at facility level on kala azar  Training of health care providers in bone marrow and spleen aspirates  Intensification of control measures

Field retrospective data collection, Marsabit County, May – June 2014

Traditional treatment of kala-azar cases marsabit county May-June 2014

Blood sample collection, Marsabit County, May – June 2014

Kala-azar case investigation team, Marsabit County, May – June 2014

END